Jean Christophe Devedjian

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

David Devos, Caroline Moreau, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2013 · 613 citations · Full text

Medicine, Neurology, Pharmacology +17

β cell expression of IGF-I leads to recovery from type 1 diabetes

Mónica George, Eduard Ayuso, Alba Casellas et al. · Journal of Clinical Investigation · 2002 · 140 citations · Full text

Life Sciences, Cell Biology, Endocrinology +14

β cell expression of IGF-I leads to recovery from type 1 diabetes

Mónica George, Eduard Ayuso, Alba Casellas et al. · Journal of Clinical Investigation · 2002 · 116 citations · Full text

Life Sciences, Cell Biology, Endocrinology +14

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau <i>et al</i> . 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Caroline Moreau, Véronique Danel, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2017 · 108 citations · Full text

Medicine, Neurology, Neuroscience +17

Osmotic induction of gene osmC expression in Escherichia coli K12

Claude Gutierrez, Jean Christophe Devedjian · Journal of Molecular Biology · 1991 · 104 citations

Life Sciences, Microbiology, Molecular Biology +10